Corticotropin-releasing hormone (CRH) is a mediator of responses to a variety of stressors, including immune challenge. CRH and the hypothalamic-pituitary-adrenal (HPA) axis constitute a negative feedback mechanism for actions of immunomodulators, such as interleukin (IL) 1. CRH is a potent inducer of waking, whereas IL-1 induces slow-wave sleep (SWS). We hypothesize that the complex changes in sleep-wake behavior during immune challenge are mediated in part by CRH and its antagonism of IL-1-induced enhancement of SWS. To further explore this hypothesis, we administered IL-1β intracerebroventricularly into rats of genetically related strains that differ in CRH/HPA axis responsiveness to IL-1 and determined subsequent alterations in their sleep-wake behavior. Sprague-Dawley rats responded to central administration of IL-1 with alterations in sleep-wake behavior as previously reported; SWS increased, and rapid eye movement sleep (REMS) and waking decreased. CRH and the HPA axis of Lewis rats are reported to be hyporesponsive to challenge; the onset of the IL-1-induced increase in SWS was quicker and the peak magnitude of the response greater than in Sprague-Dawley rats. In contrast, Fischer 344 rats exhibit greater CRH release and HPA axis activation in response to IL-1. IL-1 induced a profound and transient increase in waking of Fischer 344 rats before SWS increased. The febrile responses to IL-1 of Fischer 344 and Lewis rats were identical and of greater magnitude than those observed in Sprague-Dawley rats. Pretreatment with the CRH receptor antagonist α-helical CRH(9–41) blocked the initial IL-1-induced increase in waking of Fischer 344 rats. CRH receptor blockade did not affect the IL-1-induced alterations in sleep-wake behavior of Lewis or Sprague-Dawley rats or brain temperature of any rat strain. These observations support the hypothesis that CRH is both a modulator of responses to IL-1 and is involved in the regulation of waking.

Keywords:
Fever, Cytokines, Adrenal steroids, Corticotropin-releasing hormone, Corticotropin-releasing hormoneantagonists, Stress, Fischer 344 rats, Lewis rats, Neuroimmmune interactions
1.
Turnbull AV, Rivier C: Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 1999;79:1–71.
2.
Knudsen PJ, Dinarello CA, Strom TB: Glucocorticoids inhibit transcriptional and posttranscriptional expression of interleukin 1 in U937 cells. J Immunol 1987;139:4129–4134.
3.
Lee SW, Tsou A-P, Chan H, Thomas J, Petrie K, Eugui EM, Allison AC: Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc Natl Acad Sci USA 1988;85:1204–1208.
4.
Sternberg EM, Young WS III, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder RL: A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptiblity to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1989;86:4771–4775.
5.
Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL: Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci USA 1989;86:2374–2378.
6.
Hart BL: Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988;12:123–137.
7.
Kent S, Bluthé R-M, Kelley KW, Dantzer R: Sickness behavior as a new target for drug development. Trends Pharmacol Sci 1992;13:24–28.
8.
Krueger JM, Walter J, Dinarello CA, Wolff SM, Chedid L: Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol 1984;246:R994–R999.
9.
Susic V, Totic S: ‘Recovery’ function of sleep: Effects of purified human interleukin-1 on sleep and febrile response of cats. Metab Brain Dis 1989;4:73–80.
10.
Opp MR, Obál F, Krueger JM: Interleukin-1 alters rat sleep: Temporal and dose-related effects. Am J Physiol 1991;2650:R52–R58.
11.
Toth LA: Sleep, sleep deprivation and infectious disease: Studies in animals. Adv Neuroimmunol 1995;5:79–92.
12.
Opp MR: Rat strain differences suggest a role for corticotropin-releasing hormone in modulating sleep. Physiol Behav 1998;63:67–74.
13.
Epstein AM, Fitzsimons JT, Rolls BJ: Drinking induced by injection of angiotensin into the brain of the rat. J Physiol (Lond) 1970;210:457–474.
14.
Chang F-C, Opp MR: Blockade of corticotropin-releasing hormone receptors reduces spontaneous waking in the rat. Am J Physiol 1998;275:R793–R802.
15.
Imeri L, Bianchi S, Mancia M: Muramyl dipeptide and interleukin-1 effects on sleep and brain temperature following inhibition of serotonin synthesis. Am J Physiol 1997;273:R1663–R1668.
16.
Zelazowski P, Patchev VK, Zelazowska EB, Chrousos GP, Gold PW, Sternberg EM: Release of hypothalamic corticotropin-releasing hormone and arginine-vasopressin by interleukin 1β and αMSH: Studies in rats with different susceptibility to inflammatory disease. Brain Res 1993;631:22–26.
17.
Imeri L, Mancia M, Opp MR: Blockade of 5-HT2 receptors alters interleukin-1-induced changes in rat sleep. Neuroscience 1999;92:745–749.
18.
Opp MR, Toth LA: Somnogenic and pyrogenic effects of interleukin-1β and lipopolysaccharide in intact and vagotomized rats. Life Sci 1998;62:923–936.
19.
Born J, Späth-Schwalbe E, Schwakenhofer H, Kern W, Fehm HL: Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man. J Clin Endocrinol Metab 1989;68:904–911.
20.
Ehlers CL, Reed TK, Henriksen SJ: Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology 1986;42:467–474.
21.
Opp MR, Krueger JM: Corticotropin-releasing factor attenuates interleukin-1 induced sleep and fever in rabbits. Am J Physiol 1989;257:R528–R535.
22.
Chang F-C, Opp MR: Pituitary CRH receptor blockade reduces waking in the rat. Physiol Behav 1999;67:691–696.
23.
Chang F-C, Opp MR: IL-1 is a mediator of increases in slow-wave sleep induced by CRH receptor blockade. Am J Physiol 2000;279:R793–R802.
24.
Dhabhar FS, McEwen BS, Spencer RL: Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels – a comparison between Sprague-Dawley, Fischer 344 and Lewis rats. Brain Res 1993;616:89–98.
25.
Griffin AC, Whitacre CC: Sex and strain differences in the circadian rhythm fluctuation of endocrine and immune function in the rat: Implications for rodent models of autoimmune disease. J Neuroimmunol 1991;35:53–64.
26.
Rothwell NJ: CRF is involved in the pyrogenic and thermogenic effects of interleukin 1β in the rat. Am J Physiol 1989;256:E111–E115.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.